Kash, N; Lee, MA; Kollipara, R; Downing, C; Guidry, J; Tyring, SK (3 April 2015). «Safety and Efficacy Data on Vaccines and Immunization to Human Papillomavirus.». Journal of clinical medicine4 (4): 614-33. PMID26239350.
De Vuyst, H; Clifford, GM; Nascimento, MC; Madeleine, MM; Franceschi, S (1 April 2009). «Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis.». International journal of cancer. Journal international du cancer124 (7): 1626-36. PMID19115209.
Takes, RP; Wierzbicka, M; D'Souza, G; Jackowska, J; Silver, CE; Rodrigo, JP; Dikkers, FG; Olsen, KD και άλλοι. (December 2015). «HPV vaccination to prevent oropharyngeal carcinoma: What can be learned from anogenital vaccination programs?». Oral oncology51 (12): 1057-60. PMID26520047.
Thaxton, L; Waxman, AG (May 2015). «Cervical cancer prevention: immunization and screening 2015.». The Medical clinics of North America99 (3): 469-77. PMID25841595.
Saville, AM (30 November 2015). «Cervical cancer prevention in Australia: Planning for the future.». Cancer cytopathology. PMID26619381.
Fesenfeld, M; Hutubessy, R; Jit, M (20 August 2013). «Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.». Vaccine31 (37): 3786-804. PMID23830973.
web.archive.org
«Vaccine, Hpv». International Drug Price Indicator Guide. Αρχειοθετήθηκε από το πρωτότυπο στις 17 Δεκεμβρίου 2019. Ανακτήθηκε στις 6 Δεκεμβρίου 2015.
